iBasis, Inc. leads Wednesday small-cap pre-market volume

Tweet   

Due to stock options backdating, Internet phone service provider iBasis, Inc. (Nasdaq: IBAS) restated its 2006 annual report, adding $10.1 million for stock-based compensation.

Bear Stearns downgraded business software maker Agile Software Corp. (Nasdaq: AGIL) to “peer perform” from “outperform.”

San Diego-based Neurocrine Biosciences, Inc. (Nasdaq: NBIX) said it resubmitted its application for the insomnia drug indiplon to the FDA.

Employee training software maker Saba Software, Inc. (Nasadaq: SABA) said it expects a loss of $0.09 to $0.12 per share in the fourth quarter ended May 31, compared with a loss of $0.12 per share a year earlier.

Bethesda, Md.-based healthcare services provider Chindex International, Inc. (Nasdaq: CHDX) announced a profitable second quarter compared to a loss in the year-ago period.

Burlington, Mass.-based LeMaitre Vascular, Inc. (Nasdaq: LMAT) reported the first implant in the company’s study of its UniFit stent technology at Emory University in Atlanta, Georgia.

Oculus Innovative Sciences, Inc. (Nasdaq: OCLS) announced that the Drug Enhancement Company of America is licensing the company’s Microcyn technology for an over-the-counter “pen-like” applicator used to sterilize wounds. The 10-year licensing deal could provide Oculus with up to $47.5 million.

Portland, Ore.-based business software maker Rentrak Corp. (Nasdaq: RENT) reported a fourth quarter profit of $0.15 per share, up from $0.14 per share in the year-ago period and above analysts’ expectations of $0.11 a share.

Legal software maker EPIQ Systems, Inc. (Nasdaq: EPIQ) announced an upgraded version of its eDiscovery software. The Kansas City-based company added features that allow legal professionals to more quickly review trial and financial transaction documents.

The following are the most actively traded companies in Wednesday pre-market trading among those with market capitalizations under $500 million: